Rajarshi BanerjeeFounder

United Kingdom - Greater Oxford Area

CEO of Perspectum - a precision health company that is focused on improving the diagnosis, treatment, and management of metabolic diseases and cancer.

I studied medicine at Oxford, graduating in 2002 before moving to London to complete my general medical training and begin a specialist registrar rotation in general medicine and cardiology.

During the first two years of my general medical training, I became interested in acquired heart and liver disease. ‘At the coalface’ in medical admission units and cardiology wards there was an alarming rise in the prevalence of coexistent cardiovascular and liver disease, driven by obesity and alcohol use. I was awarded a BHF Clinical Research Training Fellowship in 2008 to study the effects of excess weight on the cardiovascular system.

In 2011, using new MR techniques developed in and patented by the Oxford Centre for Clinical Magnetic Resonance (OCMR), I began the Rapid Imaging in Liver Disease (RIAL) study in collaboration with the Translational Gastroenterology Unit, to see if advances in MR could allow us to diagnose and stage liver disease, using liver biopsy as a reference standard. The study showed that we had a high diagnostic accuracy for each of liver fat, fibrosis and iron content.

In 2012, Perspectum Ltd was incorporated. I was appointed full-time CEO in 2013.